samedan logo
 
 
 
spacer
home > pmps > winter 2003 > labelling trends expand market opportunities
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Labelling Trends Expand Market Opportunities

Labelling is an imperative part of the production process as nothing leaves the factory without a label or tag of some kind. Thankfully for the production and packaging operations requiring new coding and labelling systems, life is getting better as equipment manufacturers answer demands for easy interfacing, simple operation, quick changeover and low maintenance while at the same time providing faster throughput and higher levels of quality control.

Modern self adhesive labelling systems can 'learn' quickly and save different labelling application settings in their memories, whilst still being feature-rich and sophisticated, yet simple to use. No matter how fast coders and labellers operate there will always be a demand for higher throughputs. With many lines running at speeds of 800 or 900 per minute, the evolution of new technologies continues to help increase speeds, whilst roll-fed labelling has already reached the 800 per minute mark.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Phil Donaldson, Director of Sales and Marketing at the ALS Group

Phil Donaldson is Sales and Marketing Director for the ALS Group of Companies. Phil left university 15 years ago to work as a Programmer for Avery Labels Systems UK (now Avery Dennison), which was his first experience of labelling technology. His technical role quickly developed into sales support activities, then further into sales. He then joined MAP80 Labelling Systems where he became Sales Manager before joining ALS three years ago.

spacer
Phil Donaldson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement